Egg Enclosed In Shell Or A Part Thereof (e.g., Eggshell, Egg Yolk, Etc.) Patents (Class 424/581)
  • Patent number: 7947298
    Abstract: An animal repellent composition is disclosed that comprises a carrier base and a repellent material. The carrier base and the repellent material are mixed together in a resulting formulation that is used to provide a natural means of deterring unwanted pests and animals from the area in which the composition is used. The composition may also be used as an animal attractant depending on the formulation of the mixed materials. The formulation of the composition can be varied to produce mixtures with different consistencies and properties.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: May 24, 2011
    Inventor: Gregory A. La Torre
  • Publication number: 20110117207
    Abstract: A method to treat and alleviate symptoms of joint pain in an individual is accomplished by administering a therapeutic amount of fowl eggshell membrane or processed eggshell membrane preparations in synergistic combination with other active constituents in an oral dosage form.
    Type: Application
    Filed: November 16, 2010
    Publication date: May 19, 2011
    Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa International State of Incorporation:
    Inventors: John A. MINATELLI, W. Stephen Hill, Michael Cielensky
  • Patent number: 7906149
    Abstract: A method for treating oleoresin induced allergic dermatitis by topically contacting an affected area with a therapeutically effective amount of one or more biopolymers for a sufficient amount of time to enable the one or more biopolymers to have an effect and removing the one or more biopolymers from the affected area. The oleoresin can be urushiol, isosolenopsin A, or a combination thereof. The one or more biopolymer can be albumin. The one or more biopolymers can provide a localized anti-inflammatory effect.
    Type: Grant
    Filed: May 25, 2007
    Date of Patent: March 15, 2011
    Assignee: Boval Company, L.P.
    Inventor: Cody L. Yarborough
  • Publication number: 20110020316
    Abstract: Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.
    Type: Application
    Filed: July 21, 2010
    Publication date: January 27, 2011
    Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa International
    Inventors: John A. Minatelli, W. Stephen Hill, Swati Sebastian Thomas, Lingan Rajendran, Rudi E. Moerck
  • Publication number: 20110020466
    Abstract: Fertilized egg isolate, methods for preparing the fertilized egg isolate and uses thereof for treating mental health disorders and disease or conditions mediated by or associated with one or more glutamate receptors or by the neurokinin 2 (NK2) receptor.
    Type: Application
    Filed: January 9, 2009
    Publication date: January 27, 2011
    Applicant: United Paragon Associates Inc.
    Inventors: Jerald Bain, Hao Chen, Joel Sadavoy, David Arthur Weissman
  • Publication number: 20110014178
    Abstract: An antimicrobial composition and a method for administering the antimicrobial composition through the water or feed of livestock, wherein the antimicrobial composition is made up of lysozyme and various other agents that act synergistically with lysozyme, such as, dried egg powder, albumen, a sequestering agent and/or a lantibiotic. The composition is used to inhibit the growth of, and diseases and epidemiological significant effects caused by, Clostridium perfinigens, E, coli and Salmonella, in the gut of livestock. More particularly, the antimicrobial composition and method relate to a feed additive that can be administered to poultry and/or swine through their feed. The use of such a feed additive may also inhibit other enteric pathogens that may be present in the gut of livestock.
    Type: Application
    Filed: April 1, 2010
    Publication date: January 20, 2011
    Applicant: NEOVA TECHNOLOGIES, INC.
    Inventors: Stephen R. Smith, Stewart J. Ritchie, Guopeng Zhang
  • Publication number: 20100330192
    Abstract: The present invention is related to a method for the prevention and possibly the treatment of chronic diseases, preferably inflammatory associated chronic diseases that may affect an animal including a human, by the administration of a sufficient amount of a (functional) food or feed to the diet of this animal.
    Type: Application
    Filed: February 25, 2008
    Publication date: December 30, 2010
    Inventor: Fabien De Meester
  • Publication number: 20100254961
    Abstract: A water-soluble electrospun sheet, containing a water-soluble base material made of at least one material selected from a group consisting of: high-molecular proteins and decomposition products thereof; cellulose-based polymers; plant-based polymers and decomposition products thereof; vinyl-based polymers; acrylic-based polymers; and water-soluble polysaccharides; is provided. In addition to the water-soluble base material, the sheet may further contain at least one functional component selected from among: emulsifying components; stabilizing components; antimicrobial components; humectant components; skin-whitening components; anti-ultraviolet components; astringent components; keratin-softening components; anti-inflammatory components; and coloring components.
    Type: Application
    Filed: September 4, 2008
    Publication date: October 7, 2010
    Applicant: Taiyokagaku Co., Ltd.
    Inventors: Toshihiko Nishio, Hidetoshi Sugino, Tsutomu Okubo, Shoichi Ishigaki
  • Patent number: 7785569
    Abstract: A standardized, lyophilized edible food containing a biologically safe stable marker for use in the measurement of gastric emptying by the quantification of marker excreted in the breath of the patient.
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: August 31, 2010
    Assignee: Advanced Breath Diagnostics, LLC
    Inventors: Keith Darrel Evans, Stanley John Konopka, Kerry Clepper Bush
  • Patent number: 7758893
    Abstract: The present invention relates to an enteral composition containing phospholipids, triglycerides and cholesterol or precursors thereof, which can be used in the treatment of sepsis. With the composition of the invention the natural level of chylomicrons is maintained, in particular in gut associated lymphoid tissue (GALT), which ensures that most of LPS and/or LTA which are released in the body can be neutralized, substantially decreasing the risk of locally occurring high levels of LPS and/or LTA and thus sepsis.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: July 20, 2010
    Assignee: N.V. Nutricia
    Inventors: Robert Johan Joseph Hageman, Gelske Speelmans, Adrianus Johannes Maria Vriesema
  • Patent number: 7744625
    Abstract: The present invention provides compositions and methods for use in treatment of premature rupture of membrane. The compositions of the invention include a therapeutic amount of an avian thick egg white composition. Preferably, the compositions include the purified thick egg white protein, ovomucin. The methods of the invention involve injecting an effective amount of the compositions into the prematurely ruptured amniotic sac of a patient in order to seal the rupture.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: June 29, 2010
    Inventor: David Berry
  • Publication number: 20100151040
    Abstract: The present invention pertains to a method for the preparation of putamen ovi, putamen ovi having a defined grain size distribution, and to the use of putamen ovi for the treatment of calcium deficiency and other disease conditions.
    Type: Application
    Filed: December 9, 2009
    Publication date: June 17, 2010
    Applicant: AAR Pharma Adler Apotheke
    Inventor: Michel O. Ruepp
  • Publication number: 20100003206
    Abstract: The present invention is a cosmetic composition comprising a water-soluble protein-based film-forming agent, the film-forming agent having a tertiary structure capable of undergoing a helix-coil transformation, a protease inhibitor in an amount sufficient to protect the protein on the stratum corneum and a cosmetically acceptable vehicle so that the protease inhibitor prolongs the pulling effect of the film-forming agent.
    Type: Application
    Filed: August 14, 2009
    Publication date: January 7, 2010
    Inventors: Paolo Ulderico Giacomoni, Abul M. Manirazman, Peter J. Lentini, Gedeon Harvey
  • Publication number: 20090317484
    Abstract: A salivary substitute is produced from egg white so as to have chemical, rheological and physiological properties that are analogous to those of natural human saliva. A packaging containing the salivary substitute and uses of the salivary substitute are also disclosed.
    Type: Application
    Filed: August 28, 2007
    Publication date: December 24, 2009
    Applicant: UNITHER DEVELOPPEMENT
    Inventors: Jean Deymes, Philippe Perovitch
  • Publication number: 20090274770
    Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. This invention relates to the use of cells and cellular extracts in rejuvenation and healing technologies thereby improving healing and regeneration of all bodily tissues and organs. The present invention relates to compositions and methods of managing, preventing, and treating scars. The invention also relates to prevention of deterioration, damage and malfunction of cells and tissues, and to promote, improve or exceed cellular function in order to promote, improve and exceed appearance, vitality and health. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products.
    Type: Application
    Filed: May 7, 2009
    Publication date: November 5, 2009
    Applicant: REGENICS AS
    Inventors: Runhild Gammelsaeter, Jan Remmereit
  • Publication number: 20090263494
    Abstract: Applying the bark of the mariposa Manzanita shrub either mixed into a hot tea or added to mayonnaise and zinc for open sores will cure the herpes virus.
    Type: Application
    Filed: April 21, 2008
    Publication date: October 22, 2009
    Inventor: Robert David Emerson
  • Publication number: 20090175927
    Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. This invention relates to the use of cells and cellular extracts in rejuvenation and healing technologies thereby improving healing and regeneration of all bodily tissues and organs. The present invention relates to compositions and methods of managing, preventing, and treating scars. The invention also relates to prevention of deterioration, damage and malfunction of cells and tissues, and to promote, improve or exceed cellular function in order to promote, improve and exceed appearance, vitality and health. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products. Said components can also be synthesized.
    Type: Application
    Filed: May 11, 2007
    Publication date: July 9, 2009
    Applicant: Regenics A/S
    Inventors: Runhild Gammelsaeter, Jan Remmereit
  • Publication number: 20090092639
    Abstract: Methods and compositions for increasing antibody titer in egg yolks and for using the antibodies are disclosed.
    Type: Application
    Filed: December 17, 2008
    Publication date: April 9, 2009
    Inventors: Mark E. Cook, David L. Trott, Mingder Yang
  • Publication number: 20090074818
    Abstract: The invention relates to a composition for storage and development of eggs from helminthic parasites, where the composition further comprises a liquid carrier having a pH value of below 7 at a temperature of from 1° C. to ambient temperature. The liquid carrier can be sulphuric acid, H2SO4 with a pH in the range of from O to 2, and antibiotics can be added. The invention further relates to a method for treating, ameliorating, prophylactic or curative, an autoimmune or allergic disease in an individual, animal or man, using eggs being separated from the composition. The present invention also relates to methods for isolation, embryonation and preservation of eggs of helminthic parasite, and to a method for producing a pharmaceutical composition comprising a helminthic parasite preparation. The helminthic parasite eggs may be from the pig whipworm; Trichuris suis ova (TSO).
    Type: Application
    Filed: December 29, 2006
    Publication date: March 19, 2009
    Inventors: Christian Mollin Outzen Kapel, Allan Roepstorff, Stig Milan Thamsborg
  • Patent number: 7479287
    Abstract: A dormant preparation (DC) is provided which is capable of inhibiting proliferation of various kinds of cells. The preparation comprises an extract which is obtained from cells or tissue originating in an organism capable of entering a phase of dormancy in at least one of its parts and comprises at least one substance which induces or maintains the state of dormancy in the organism from which the cells or tissue are derived. The DC may be used for a variety of indications including human medicine and cosmetics, plant growth control and food preservation.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: January 20, 2009
    Assignee: I.B.R., Israeli Biotechnology Research, Ltd.
    Inventors: Etienne Soudant, Lea Bezalel, Meira Ziv, Inon Perry
  • Publication number: 20080286200
    Abstract: A standardized, lyophilized edible food containing a biologically safe stable marker for use in the measurement of gastric emptying by the quantification of marker excreted in the breath of the patient.
    Type: Application
    Filed: May 15, 2008
    Publication date: November 20, 2008
    Applicant: Advanced Breath Diagnostics, LLC
    Inventors: Kerry C. Bush, Keith D. Evans, Stanley J. Konopka
  • Patent number: 7186424
    Abstract: The present invention is a multifunctional nutrient supplement and a process for creating the supplement. The supplement comprises a mixture of lecithin, ginkgo biloba and wheat germ oil. The supplement is made with a five step formation process. The first step of the process uses CO2 supercritical extraction to remove cholesterol, glyceride and fatty acids from an egg yolk. Wheat germ oil is then obtained from dried wheat germ using CO2 supercritical extraction. Gingko biloba is then removed from ginkgo leaves using CO2 supercritical extraction. The egg yolk/lecithin from the first extraction is then combined with the wheat germ oil from the second extraction. Ethanol is then added to the mixture of lecithin and wheat germ oil and low temperature vacuum distilled to create a lecithin and wheat germ oil mixture. The ginkgo biloba extract is then added to the lecithin/wheat germ oil mixture to create the nutrient supplement.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: March 6, 2007
    Inventors: Ming Xie, Dingzhong Xie, Yong Feng, Hui Zeng
  • Patent number: 7087429
    Abstract: A process for obtaining a substance with growth promoting activity that includes the step of isolating perivitelline fluid from a fertilized egg of a horseshoe crab. Also, a process for proliferating cells including the steps of isolating perivitelline fluid from a fertilized egg of a horseshoe crab and growing the cells in the presence of the isolated perivitelline fluid.
    Type: Grant
    Filed: March 24, 2004
    Date of Patent: August 8, 2006
    Assignee: Department of Biotechnology and Council of Scientific and Industrial Research
    Inventors: Pradeep Bhaskar Parab, Anil Chatterji
  • Patent number: 7083809
    Abstract: Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-?), interleukin-1-beta (IL-1?), and interleukin-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition.
    Type: Grant
    Filed: February 11, 2003
    Date of Patent: August 1, 2006
    Assignee: Arkion Life Sciences, LLC
    Inventors: Subramanian Iyer, William L. Johnson, Lance Nguyen, Steven C. Ross, Ruye Xing
  • Patent number: 7033601
    Abstract: The present invention is a composition and method for repelling squamate reptiles, such as without limitation snakes. The composition comprises mint oil, garlic oil, putrescent egg solids, thyme oil white, sodium lauryl sulfate and water. This composition is applied to snakes' habitats or perimeters around homes, buildings, patios, decks and the like to repel squamate reptiles, such as without limitation snakes.
    Type: Grant
    Filed: May 10, 2005
    Date of Patent: April 25, 2006
    Assignee: Liquid Holding Company, Inc.
    Inventor: George Ferko, IV
  • Patent number: 7011853
    Abstract: The present invention pertains to a method for the preparation of putamen ovi, putamen ovi having a defined grain size distribution, and to the use of putamen ovi for the treatment of calcium deficiency and other disease conditions.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: March 14, 2006
    Assignee: AAR Pharma Adler Apotheke
    Inventor: Michel O. Ruepp
  • Patent number: 6936284
    Abstract: To conduct a search for natural drugs and their formulae derived from natural substances that hardly cause side effects and drug tolerance, based on quite a new idea having departed from conventional drugs such as Chinese galenicals, Chinese medicine formulae, etc. and to develop a composition that has an anticancer activity and is selectively cytotoxic to cancer cells. A composition having an anticancer effect is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and a dry product of Theaceae Camellia. Also, a composition having an anticancer activity is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and/or a dry product of Theaceae Camellia together with a dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein an additive comprising a dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia.
    Type: Grant
    Filed: October 9, 2002
    Date of Patent: August 30, 2005
    Assignee: Iijima Corporation
    Inventors: Hideshi Iijima, Aizo Iijima
  • Patent number: 6866868
    Abstract: A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: March 15, 2005
    Assignee: 4Life Research, LC
    Inventors: David Lisonbee, William J. Hennen, F. Joseph Daugherty
  • Patent number: 6863903
    Abstract: The invention generally relates to the use of natural anti-secretory protein (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as a source of NASP.
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: March 8, 2005
    Assignee: Rural Patent Svenska AB
    Inventors: Stefan Lange, Leif Göransson, Ivar Lönnroth
  • Publication number: 20040219171
    Abstract: The present invention is directed to processes and compositions for protecting host animals (e.g., chickens) from exposure to virulent infectious bronchitis virus. In ovo administration of live, avirulent strains of IB at appropriate dosage levels on a per egg basis provides an effective and efficient vaccination having acceptable safety and efficacy features.
    Type: Application
    Filed: June 1, 2004
    Publication date: November 4, 2004
    Applicant: Wyeth
    Inventors: Berend Jongsma, Frans Gerrit Davelaar, Marinus Wynand Weststrate
  • Patent number: 6803035
    Abstract: A food product and method for treating and preventing diarrhea in a subject animal suffering from or susceptible to diarrhea. The method comprises administering an egg product to the subject animal wherein the egg product is obtained from a hyperimmunized avian.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: October 12, 2004
    Assignee: Arkion Life Sciences
    Inventors: Hellen Chaya Greenblatt, Orn Adalsteinsson, David A. Brodie, Henry Jacoby
  • Patent number: 6790457
    Abstract: Disclosed is an immunocontraceptive vaccine composition comprising a teleost homolog of zona pellucida (TH-ZP), together with a pharmaceutically acceptable diluent or carrier, for reducing or preventing fertilization in a fish, and a method for its use. Also disclosed is immunocontraceptive vaccine composition comprising an antigen from an inner perivitelline layer (IPVL), together with a pharmaceutically acceptable diluent or carrier, for reducing or preventing fertilization in a bird, and a method for its use.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: September 14, 2004
    Assignee: Dalhousie University
    Inventors: Robert Brown, Bill Pohajdak, Janet Horrocks, Leslie McLaren
  • Patent number: 6776991
    Abstract: A method for treating priapism in a mammal by administration of a botulinum toxin.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: August 17, 2004
    Assignee: Allergan, Inc.
    Inventor: Markus K. Naumann
  • Patent number: 6720010
    Abstract: To conduct a search for natural drugs and their formulae derived from natural substances that hardly cause side effects and drug tolerance, based on quite a new idea having departed from conventional drugs such as Chinese galenicals, Chinese medicine formulae, etc. and to develop a composition that has an antihepatitic activity. A composition having an antihepatitic activity is provided, which comprises a dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein an additive comprising a dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia. The composition may contain a dry product of Angelica keiskei and optionally a dry product of Theaceae Camellia. The compositions have antihepatitic activity and are derived from natural substances.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: April 13, 2004
    Assignee: Iijima Corporation
    Inventors: Hideshi Iijima, Aizo Iijima
  • Publication number: 20030219492
    Abstract: The present invention provides compositions and methods for use in treatment of premature rupture of membranes. The compositions of the invention include a therapeutic amount of an avian thick egg white composition. Preferably, the compositions include the purified thick egg white protein, ovomucin. The methods of the invention involve injecting an effective amount of the compositions into the prematurely ruptured amniotic sac of a patient in order to seal the rupture.
    Type: Application
    Filed: October 23, 2002
    Publication date: November 27, 2003
    Inventor: David Berry
  • Patent number: 6652846
    Abstract: The invention relates to attractants for use in yellow jacket traps. The attractants have improved overall effectiveness in attracting yellow jackets, in attracting a broader spectrum of yellow jacket species and in attracting yellow jackets in the several phases of their life cycles when their food requirements vary. The attractants are distinguished by the inclusion of a weak acid in the attractant formulation. The preferred weak acid is acetic acid and its preferred form is a vinegar.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: November 25, 2003
    Inventor: Roger H. Long
  • Publication number: 20030211226
    Abstract: A method of detoxifying the egg of puffer fish for creating healthy foodstuffs which includes the steps of heating the eggs of puffer fish and ginger root at a temperature of 100-200° C. for 30-40 minutes and drying the heated egg composition, and repeating the heating and drying steps a multiplicity of times to produce a detoxified product.
    Type: Application
    Filed: August 6, 2002
    Publication date: November 13, 2003
    Inventors: Sang Kuen Kim, Byoug Ki Kim, Jung Sik Shin, Jin San Shin
  • Patent number: 6642202
    Abstract: The object of the present invention is to allow an egg originally having almost no active oxygen eliminating ability, to strongly possess an active oxygen eliminating ability. It was found that an egg containing a high level of iodine (4.2 ppm or more) has an ability to eliminate active oxygen, which acts harmfully on the human body.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: November 4, 2003
    Assignee: Nosan Corporation
    Inventors: Kunitoshi Sekimoto, Akiko Matsuki, Ayuko Kashimori
  • Patent number: 6627229
    Abstract: An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the animal such as clamshell, eggshell, crustacean shell, bone, coral, and pearl, and calcium carbonate-containing minerals such as limestone. When a temperature of the heat treatment is not less than 650° C. and less than a melting point of the calcium component-containing substance, a sufficient time of the heat treatment is 2 to 13 hours.
    Type: Grant
    Filed: June 23, 2001
    Date of Patent: September 30, 2003
    Inventors: Kazutomo Kikuchi, Noriaki Kikuchi
  • Publication number: 20030180318
    Abstract: To conduct a search for natural drugs and their formulae derived from natural substances that hardly cause side effects and drug tolerance, based on quite a new idea having departed from conventional drugs such as Chinese galenicals, Chinese medicine formulae, etc. and to develop a composition that has an anticancer activity and is selectively cytotoxic to cancer cells. A composition having an anticancer effect is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and a dry product of Theaceae Camellia. Also, a composition having an anticancer activity is obtained, which comprises therapeutically effective amounts of a dry product of Angelica keiskei and/or a dry product of Theaceae Camellia together with a dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein an additive comprising a dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia.
    Type: Application
    Filed: October 9, 2002
    Publication date: September 25, 2003
    Applicant: Iijima Corporation
    Inventors: Hideshi Iijima, Aizo Iijima
  • Publication number: 20030175359
    Abstract: The object of the present invention is to allow an egg originally having almost no active oxygen eliminating ability, to strongly possess an active oxygen eliminating ability. It was found that an egg containing a high level of iodine (4.2 ppm or more) has an ability to eliminate active oxygen, which acts harmfully on the human body.
    Type: Application
    Filed: March 12, 2002
    Publication date: September 18, 2003
    Inventors: Kunitoshi Sekimoto, Akiko Matsuki, Ayuko Kashimori
  • Publication number: 20030152641
    Abstract: Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-&agr;), interleukin-1-beta (IL-1&bgr;), and interleukin-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition.
    Type: Application
    Filed: February 11, 2003
    Publication date: August 14, 2003
    Inventors: Subramanian Iyer, William L. Johnson, Lance Nguyen, Steven C. Ross, Ruye Xing
  • Publication number: 20030143285
    Abstract: The invention generally relates to the use of natural anti-secretory protein (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as a source of NASP.
    Type: Application
    Filed: February 7, 2003
    Publication date: July 31, 2003
    Inventors: Stefan Lange, Leif Goransson, Ivar Lonnroth
  • Publication number: 20030143284
    Abstract: The invention generally relates to the use of natural anti-secretory proteins (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as source of NASP.
    Type: Application
    Filed: February 7, 2003
    Publication date: July 31, 2003
    Inventors: Stefan Lange, Leif Goransson, Ivar Lonnroth
  • Publication number: 20030133989
    Abstract: The present invention provides a skin care product comprising whole egg, an emollient substance and a humectant substance, colostrum, lactoferrin and/or methyl sulfonyl methane (MSM).
    Type: Application
    Filed: October 1, 2002
    Publication date: July 17, 2003
    Inventor: Michael Marenick
  • Publication number: 20030068314
    Abstract: A food product and method for treating and preventing diarrhea in a subject animal suffering from or susceptible to diarrhea. The method comprises administering an egg product to the subject animal wherein the egg product is obtained from a hyperimmunized avian.
    Type: Application
    Filed: January 22, 2002
    Publication date: April 10, 2003
    Inventors: Hellen Chaya Greenblatt, Orn Adalsteinsson, David A. Brodie, Henry Jacoby
  • Patent number: 6541447
    Abstract: A composition for wound healing and hair growth is disclosed. The composition comprises at least 5.0% by weight of ovalbumin, about 1.0% phenoxyethanol, about 0.5% carbomer, and about 0.3% triethanolamine. The composition may be in the form of a cream, powder, lotion, gel, emulsion, or ointment. Its method for use in wound healing and for hair growth is also disclosed.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: April 1, 2003
    Assignee: B & M Healthcare Technologies, Inc.
    Inventor: Monica E. Dawson
  • Publication number: 20030059480
    Abstract: Although compositions from seaweed have long been sought after for beneficial properties for the skin, the ability to produce efficacious compositions has been elusive. An intra-lamellar gel, produced from marine algae, has been found to enhance the condition of skin and hair. Milt, optionally in combination with intra-lamellar gel, also provides a composition useful for application to the skin or hair.
    Type: Application
    Filed: March 29, 2002
    Publication date: March 27, 2003
    Inventor: Diane C. Boratyn
  • Patent number: 6537588
    Abstract: The invention generally relates to the use of natural anti-secretory proteins (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as source of NASP.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: March 25, 2003
    Assignee: Rural Patent Svenska AB
    Inventors: Stefan Lange, Leif Göransson, Ivar Lönnroth
  • Patent number: 6534097
    Abstract: A pest deterrent compound includes water, calcium carbonate and hydrogen sulfide. The compound is successful in deterring white flies and other destructive insects from attacking plants. The plant is protected by pouring a liquid solution onto the plant and the ground underneath and around the plant. The compound is absorbed into the plant's leaves and roots and acts as a deterrent against destructive insects. The pest deterrent compound is given in the following formula.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: March 18, 2003
    Inventor: Betty Baggott